An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Stopped The termination was due to business reasons. No safety or efficacy concerns contributed to the termination of the study

Conditions

• Asthma

Interventions

• DRUG: Placebo
• DRUG: PF-03715455

Sponsor

Pfizer